These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 29513049)
1. Eph A10-modified pH-sensitive liposomes loaded with novel triphenylphosphine-docetaxel conjugate possess hierarchical targetability and sufficient antitumor effect both in vitro and in vivo. Zhang J; Yang C; Pan S; Shi M; Li J; Hu H; Qiao M; Chen D; Zhao X Drug Deliv; 2018 Nov; 25(1):723-737. PubMed ID: 29513049 [TBL] [Abstract][Full Text] [Related]
2. RGD-modified pH-sensitive liposomes for docetaxel tumor targeting. Chang M; Lu S; Zhang F; Zuo T; Guan Y; Wei T; Shao W; Lin G Colloids Surf B Biointerfaces; 2015 May; 129():175-82. PubMed ID: 25851582 [TBL] [Abstract][Full Text] [Related]
3. Multifunctional tumor-targeting nanocarriers based on hyaluronic acid-mediated and pH-sensitive properties for efficient delivery of docetaxel. Song S; Chen F; Qi H; Li F; Xin T; Xu J; Ye T; Sheng N; Yang X; Pan W Pharm Res; 2014 Apr; 31(4):1032-45. PubMed ID: 24154802 [TBL] [Abstract][Full Text] [Related]
4. NGR-modified pH-sensitive liposomes for controlled release and tumor target delivery of docetaxel. Gu Z; Chang M; Fan Y; Shi Y; Lin G Colloids Surf B Biointerfaces; 2017 Dec; 160():395-405. PubMed ID: 28965079 [TBL] [Abstract][Full Text] [Related]
5. Triphenylphosphine-docetaxel conjugate-incorporated albumin nanoparticles for cancer treatment. Battogtokh G; Gotov O; Kang JH; Cho J; Jeong TH; Chimed G; Ko YT Nanomedicine (Lond); 2018 Feb; 13(3):325-338. PubMed ID: 29338573 [TBL] [Abstract][Full Text] [Related]
6. Mitochondria-targeted delivery of doxorubicin to enhance antitumor activity with HER-2 peptide-mediated multifunctional pH-sensitive DQAsomes. Shi M; Zhang J; Li X; Pan S; Li J; Yang C; Hu H; Qiao M; Chen D; Zhao X Int J Nanomedicine; 2018; 13():4209-4226. PubMed ID: 30140154 [TBL] [Abstract][Full Text] [Related]
7. Docetaxel-loaded RIPL peptide (IPLVVPLRRRRRRRRC)-conjugated liposomes: Drug release, cytotoxicity, and antitumor efficacy. Yoon HY; Kwak SS; Jang MH; Kang MH; Sung SW; Kim CH; Kim SR; Yeom DW; Kang MJ; Choi YW Int J Pharm; 2017 May; 523(1):229-237. PubMed ID: 28341149 [TBL] [Abstract][Full Text] [Related]
8. Comparison of two kinds of docetaxel-vitamin E prodrugs: In vitro evaluation and in vivo antitumor activity. Wang J; Xue P; Zhou J; Li L; Xu L; Wang Y Int J Pharm; 2016 May; 505(1-2):352-60. PubMed ID: 27085643 [TBL] [Abstract][Full Text] [Related]
9. RGD(Arg-Gly-Asp) internalized docetaxel-loaded pH sensitive liposomes: Preparation, characterization and antitumor efficacy in vivo and in vitro. Zuo T; Guan Y; Chang M; Zhang F; Lu S; Wei T; Shao W; Lin G Colloids Surf B Biointerfaces; 2016 Nov; 147():90-99. PubMed ID: 27497073 [TBL] [Abstract][Full Text] [Related]
10. Tumor-targeting, pH-sensitive nanoparticles for docetaxel delivery to drug-resistant cancer cells. Tran TH; Ramasamy T; Choi JY; Nguyen HT; Pham TT; Jeong JH; Ku SK; Choi HG; Yong CS; Kim JO Int J Nanomedicine; 2015; 10():5249-62. PubMed ID: 26346426 [TBL] [Abstract][Full Text] [Related]
11. In vitro characterization of pH-sensitive Bletilla Striata polysaccharide copolymer micelles and enhanced tumour suppression in vivo. Zhao L; Sun D; Lu H; Han B; Zhang G; Guan Q J Pharm Pharmacol; 2018 Jun; 70(6):797-807. PubMed ID: 29485227 [TBL] [Abstract][Full Text] [Related]
12. Tumour microenvironment-responsive lipoic acid nanoparticles for targeted delivery of docetaxel to lung cancer. Gu F; Hu C; Tai Z; Yao C; Tian J; Zhang L; Xia Q; Gong C; Gao Y; Gao S Sci Rep; 2016 Nov; 6():36281. PubMed ID: 27805051 [TBL] [Abstract][Full Text] [Related]
13. Novel pH-sensitive charge-reversal cell penetrating peptide conjugated PEG-PLA micelles for docetaxel delivery: in vitro study. Ouahab A; Cheraga N; Onoja V; Shen Y; Tu J Int J Pharm; 2014 May; 466(1-2):233-45. PubMed ID: 24614579 [TBL] [Abstract][Full Text] [Related]
14. Preparation, characterization, and pharmacodynamics of thermosensitive liposomes containing docetaxel. Zhang H; Gong W; Wang ZY; Yuan SJ; Xie XY; Yang YF; Yang Y; Wang SS; Yang DX; Xuan ZX; Mei XG J Pharm Sci; 2014 Jul; 103(7):2177-2183. PubMed ID: 24846075 [TBL] [Abstract][Full Text] [Related]
15. Redox-responsive polymeric micelles formed by conjugating gambogic acid with bioreducible poly(amido amine)s for the co-delivery of docetaxel and MMP-9 shRNA. Kang Y; Lu L; Lan J; Ding Y; Yang J; Zhang Y; Zhao Y; Zhang T; Ho RJY Acta Biomater; 2018 Mar; 68():137-153. PubMed ID: 29288085 [TBL] [Abstract][Full Text] [Related]
16. PEG-PCL based micelle hydrogels as oral docetaxel delivery systems for breast cancer therapy. Wang Y; Chen L; Tan L; Zhao Q; Luo F; Wei Y; Qian Z Biomaterials; 2014 Aug; 35(25):6972-85. PubMed ID: 24836952 [TBL] [Abstract][Full Text] [Related]
17. pH-Responsive hyaluronated liposomes for docetaxel delivery. Lee JM; Park H; Oh KT; Lee ES Int J Pharm; 2018 Aug; 547(1-2):377-384. PubMed ID: 29902507 [TBL] [Abstract][Full Text] [Related]
18. Transporter occluded-state conformation-induced endocytosis: Amino acid transporter ATB Luo Q; Gong P; Sun M; Kou L; Ganapathy V; Jing Y; He Z; Sun J J Control Release; 2016 Dec; 243():370-380. PubMed ID: 27810556 [TBL] [Abstract][Full Text] [Related]
19. Effective deactivation of A549 tumor cells in vitro and in vivo by RGD-decorated chitosan-functionalized single-walled carbon nanotube loading docetaxel. Li B; Zhang XX; Huang HY; Chen LQ; Cui JH; Liu Y; Jin H; Lee BJ; Cao QR Int J Pharm; 2018 May; 543(1-2):8-20. PubMed ID: 29535039 [TBL] [Abstract][Full Text] [Related]
20. Development and characterization of docetaxel-loaded lecithin-stabilized micellar drug delivery system (L Su CY; Liu JJ; Ho YS; Huang YY; Chang VH; Liu DZ; Chen LC; Ho HO; Sheu MT Eur J Pharm Biopharm; 2018 Feb; 123():9-19. PubMed ID: 29154834 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]